Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through Aβ/Kv2.1/microglial NLRP3/neuronal Tau axis
aSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
bJiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
cSchool of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
dState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing 210023, China
* Corresponding authors.
收起